Warner Bros. Discovery, Inc.
Cyclic compound acting as PDE4 inhibitor

Last updated:

Abstract:

Provided are a phosphodiesterase-4 (PDE4) inhibitor and application thereof in preparation of a medication for treating a disease related to PDE4. Specifically disclosed is a compound as shown in formula (I) and a pharmaceutically acceptable salt thereof. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

22 Aug 2017

Issue date:

14 Jan 2020